000 | 01986 a2200565 4500 | ||
---|---|---|---|
005 | 20250516214843.0 | ||
264 | 0 | _c20150828 | |
008 | 201508s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.03112-14 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoffman, Paul S | |
245 | 0 | 0 |
_aPreclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cAug 2014 |
||
300 |
_a4703-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xblood |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aBenzamides _xblood |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 |
_aHelicobacter Infections _xblood |
650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
650 | 0 | 4 |
_aHepatocytes _xcytology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aMicrobiota _xdrug effects |
650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
650 | 0 | 4 |
_aPyruvate Synthase _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aThiamine Pyrophosphate _xmetabolism |
650 | 0 | 4 |
_aThiazoles _xblood |
700 | 1 | _aBruce, Alexandra M | |
700 | 1 | _aOlekhnovich, Igor | |
700 | 1 | _aWarren, Cirle A | |
700 | 1 | _aBurgess, Stacey L | |
700 | 1 | _aHontecillas, Raquel | |
700 | 1 | _aViladomiu, Monica | |
700 | 1 | _aBassaganya-Riera, Josep | |
700 | 1 | _aGuerrant, Richard L | |
700 | 1 | _aMacdonald, Timothy L | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 58 _gno. 8 _gp. 4703-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.03112-14 _zAvailable from publisher's website |
999 |
_c23881868 _d23881868 |